Investors have never been faced with a market which is so wide open while the market is in its infancy. We know the market in Canada and the United States will multiply by at least five times, and perhaps by 10 times or more. That is going to create many stock market successes. Picking who will finish first in this very quickly maturing group… that’s extraordinarily difficult. The market has already recognized one group of winners. We’re talking about the biggest Canadian producers… those who “planted their flag” not only in the Canadian market, but in the developing European medical Cannabis market. I am convinced that those companies able to establish reputable, reliable, recognizable brands will be the second, and bigger, set of winners—and most investors have not yet come to this realization. That creates an opportunity to make colossally sized gains from a new set of stocks. Brands will be so important because they’ve always been important to consumers. When a consumer goes to buy orange juice, he or she might have an idea of the varietal in mind… the part of the world he or she is looking to have juice from… but most likely something that is a known brand. Maybe it’ll be low to medium priced juice. And as our consumer moves up the value chain, brands become even more important. That brand is what tells consumers what to expect from the product. At the very high end, the way people plan their Investor’s Report to Cannabis is no different. People will want different types, or at least different effects. But they will come to depend on brands to tell them what to expect, rather than having to become a Cannabis guru. The companies that realize the importance of branding and have chosen to build their brand where consumers are choosiest of all: Medical Cannabis. Consumers who currently have to ask their doctors or quiz overworked retail associates at a dispensary to find the right mix of THC and CBD can count on their brand to get exactly what they want every time they buy.